🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are urged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Commerce on Social Networks

Additionally, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, physicians and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of uncertain source.

Several professionals stated the demand for retatrutide could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, risking penalties, prosecution or prison.

Platform Reaction and Material Elimination

Based on the social media company, the platform has removed violative content and prohibited associated keywords and search suggestions. The company said it was dedicated to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Activities

Investigations also discovered groups with up to nine thousand participants marketing retatrutide using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with numerous of users, filled with photos of weight loss, glowing reviews and step-by-step guides for preparing or administering at home.

Within minutes of entering one group, a vendor posted WhatsApp details, where most purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.

Product Information and Costs

Inside these groups, messages display black plastic parcels with postal service stickers, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A spokesperson for Telegram stated it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already encountered individuals harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to potentially serious health risks”.